Status Migrainosus - Differentiating Between Responders and Non-responders

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Migraine

In brief

The main goal of this study is to determine whether it is possible - in the setup of routine clinical care - to identify in individual patients who are clear responders to drug X, common denominators that are absent in individual patients who are non-responders to the same drug, and vice versa. All currently available knowledge about migraine pathophysiology will be utilized, using as much time as is needed to ask as many questions as are necessary, in an attempt to profile clear responders and clear non-responders.

Key facts

Study ID

NCT03066544

Run by

Hartford HealthCare

People needed

50

Starts

2016-11-30

Expected to finish

2020-06-30

Last updated by the study team

2018-08-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• males and females
• ≥18 years old with no upper age limit
• patients with status migrainosus - defined as a severe migraine headache without aura lasting longer than 72 hours and considered primarily as a complication of migraine
• patients who are willing and able to provide written, informed consent

You may not qualify if…

• <18 years old
• unable or unwilling to provide written, informed consent
• females who are pregnant, breastfeeding, or who are trying to become pregnant
• patients who do not speak English
• any medical condition or other reason that in the opinion of the investigators makes the patient unfit or at risk to participate in the study

Where it is running

• Hartford HealthCare Headache Center — Wethersfield, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.